ZONEGRAN

This brand name is authorized in United States. It is also authorized in Australia, Austria, Croatia, Cyprus, Estonia, Finland, France, Germany, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug ZONEGRAN contains one active pharmaceutical ingredient (API):

1	Zonisamide UNII 459384H98V - ZONISAMIDE
	Zonisamide is a benzisoxazole derivative with antiepileptic and anticonvulsant activity. The mechanism of action of zonisamide is not fully elucidated, but it appears to act on voltage-sensitive sodium and calcium channels, thereby disrupting synchronised neuronal firing, reducing the spread of seizure discharges and disrupting subsequent epileptic activity.
	Read more about Zonisamide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZONEGRAN Hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N03AX15	Zonisamide	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AX Other antiepileptics
Discover more medicines within N03AX15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	9388D, 9389E, 9390F
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00098861, 01309627, 01309633, 01557957, 01557963, 01610309, 01697463, 02475322, 02667004, 03772217, 03772246, 04132891, 04407224, 04407276, 04407282, 04407299, 04407307, 04595421, 04595438, 05500581, 06698177, 06786680, 06786697, 06786705, 06793958, 06876762, 06876779, 10419119, 10917024, 10917030, 11103200, 11541064, 11542916, 12344360, 12381119, 12477919, 12509921, 12529444, 12529450, 12561376, 12571966, 12573244, 12801308, 13830832, 13928726, 14016393, 14016401, 14178374, 14220277, 15612499
EE	Ravimiamet	1196018, 1196029, 1196030, 1196041, 1196052, 1196063, 1196074, 1196085, 1196096, 1196108, 1454846, 1454857, 1454868, 1488630, 1488641, 1488652, 1488663, 1488674, 1488685, 1488696, 1488708
ES	Centro de información online de medicamentos de la AEMPS	04307001, 04307004, 04307004IP, 04307004IP1, 04307004IP2, 04307004IP3, 04307009, 04307009IP
FI	Lääkealan turvallisuus- ja kehittämiskeskus	027622, 027632, 030333
FR	Base de données publique des médicaments	61088036, 64122807, 69287499
GB	Medicines & Healthcare Products Regulatory Agency	147380, 147385, 164519, 164521, 164522, 182154, 186213, 186215, 186300, 369187, 375457, 375461, 375463, 93036, 93040, 93042
IE	Health Products Regulatory Authority	13231, 50563, 53407, 53429, 53461, 57891, 74805, 74806, 74832, 74863, 74865, 74866
IT	Agenzia del Farmaco	036959017, 036959043, 036959094
LT	Valstybinė vaistų kontrolės tarnyba	1031510, 1031511, 1031512, 1031513, 1031514, 1031515, 1031516, 1031517, 1031518, 1031519, 1031520, 1031521, 1031522, 1056111, 1056112, 1056113, 1056114, 1056115, 1056116, 1056117, 1056118
NL	Z-Index G-Standaard, PRK	95281, 95303, 95311
PL	Rejestru Produktów Leczniczych	100312937, 100312943, 100312950, 100312966, 100312972, 100312989, 100312995
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W51778001, W51778002, W51778003, W51778004, W51779001, W51779002, W51779003, W51779004, W51780001, W51780002, W51780003, W51780004, W51780005
US	FDA, National Drug Code	59212-680, 59212-681